4:29 PM ET
8-K
Executive Compensation
Kiniksa Pharmaceuticals International Executive Compensation
Kiniksa Pharmaceuticals appointed Ross Moat as President and Chief Operating Officer, effective immediately. The company also approved an increase in Moat's annual base salary to $700,000 and his annual target bonus to 60%, effective January 1, 2027.